Immunocore Holdings plc (IMCR) Gross margin 2021–2025
Immunocore Holdings plc (IMCR) gross margin by fiscal year — reported gross profit divided by reported revenue.
98.7%FY2025 · since FY2021: 100.0% → 98.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 98.7% | -0.4 pp |
| FY2024 | 99.1% | -0.5 pp |
| FY2023 | 99.6% | +0.2 pp |
| FY2022 | 99.4% | -0.6 pp |
| FY2021 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More IMCR financial trends
IMCR RevenueIMCR Net incomeIMCR Net marginIMCR Gross profitIMCR Operating incomeIMCR Operating marginIMCR Operating cash flowIMCR Free cash flowIMCR Capital expendituresIMCR Return on equityIMCR Stock buybacksIMCR Dividends paidIMCR Total assetsIMCR Total liabilitiesIMCR Shareholders’ equityIMCR overview →